Search research articles
Contact Us
Filters
Showing results (61-70 of 117) with videos related to
Page
of 12
Sort By:
Small (Weinheim an Der Bergstrasse, Germany)
|
January 14, 2026
Intrinsic Relaxor-Like Nature in Single-Component Polar Nematic Fluids
Fan Ye, Yanyun Hou, Chen Yang, et al.
Physical Chemistry Chemical Physics : PCCP
|
May 4, 2022
Development of emergent ferroelectric nematic liquid crystals with highly fluorinated and rigid mesogens
Yaohao Song, Jinxing Li, Runli Xia, et al.
Journal of Virological Methods
|
May 10, 2008
A highly sensitive and reproducible HCV RNA hybridization method valuable for antiviral drug discovery
Yongsen Zhao, Amy Sanchez, Xingtie Nie, et al.
Antimicrobial Agents and Chemotherapy
|
April 16, 2008
Selection of replicon variants resistant to ACH-806, a novel hepatitis C virus inhibitor with no cross-resistance to NS3 protease and NS5B polymerase inhibitors
Wengang Yang, Yongsen Zhao, Joanne Fabrycki, et al.
Nature Communications
|
October 22, 2025
Liquid-matter relaxor ferroelectrics by design
Xinxin Zhang, Yu Zou, Minghui Deng, et al.
Nature Communications
|
May 26, 2026
Self-charged polar nematic monopoles and hybrid topological states: intertwining and domain integration
Yu Zou, Jidan Yang, Zhongjie Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2024
Chiral π domain walls composed of twin half-integer surface disclinations in ferroelectric nematic liquid crystals
Shengzhu Yi, Zening Hong, Zhongjie Ma, et al.
PNAS Nexus
|
December 20, 2024
Half-integer topological defects paired via string micelles in polar liquids
Zhongjie Ma, Miao Jiang, Yaohao Song, et al.
Pharmaceutical Research
|
June 25, 2025
First-in-Class Clinically Investigated Oral Factor D Inhibitors for the Treatment of Complement-Mediated Diseases
Venkat R Gadhachanda, Jason A Wiles, Steven D Podos, et al.
Pharmaceutical Research
|
July 14, 2025
Correction: First-in-Class Clinically Investigated Oral Factor D Inhibitors for the Treatment of Complement-Mediated Diseases
Venkat R Gadhachanda, Jason A Wiles, Steven D Podos, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 117) with videos related to
Sort By:
Page
of 12
Small (Weinheim an Der Bergstrasse, Germany)
|
January 14, 2026
Intrinsic Relaxor-Like Nature in Single-Component Polar Nematic Fluids
Fan Ye, Yanyun Hou, Chen Yang, et al.
Physical Chemistry Chemical Physics : PCCP
|
May 4, 2022
Development of emergent ferroelectric nematic liquid crystals with highly fluorinated and rigid mesogens
Yaohao Song, Jinxing Li, Runli Xia, et al.
Journal of Virological Methods
|
May 10, 2008
A highly sensitive and reproducible HCV RNA hybridization method valuable for antiviral drug discovery
Yongsen Zhao, Amy Sanchez, Xingtie Nie, et al.
Antimicrobial Agents and Chemotherapy
|
April 16, 2008
Selection of replicon variants resistant to ACH-806, a novel hepatitis C virus inhibitor with no cross-resistance to NS3 protease and NS5B polymerase inhibitors
Wengang Yang, Yongsen Zhao, Joanne Fabrycki, et al.
Nature Communications
|
October 22, 2025
Liquid-matter relaxor ferroelectrics by design
Xinxin Zhang, Yu Zou, Minghui Deng, et al.
Nature Communications
|
May 26, 2026
Self-charged polar nematic monopoles and hybrid topological states: intertwining and domain integration
Yu Zou, Jidan Yang, Zhongjie Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2024
Chiral π domain walls composed of twin half-integer surface disclinations in ferroelectric nematic liquid crystals
Shengzhu Yi, Zening Hong, Zhongjie Ma, et al.
PNAS Nexus
|
December 20, 2024
Half-integer topological defects paired via string micelles in polar liquids
Zhongjie Ma, Miao Jiang, Yaohao Song, et al.
Pharmaceutical Research
|
June 25, 2025
First-in-Class Clinically Investigated Oral Factor D Inhibitors for the Treatment of Complement-Mediated Diseases
Venkat R Gadhachanda, Jason A Wiles, Steven D Podos, et al.
Pharmaceutical Research
|
July 14, 2025
Correction: First-in-Class Clinically Investigated Oral Factor D Inhibitors for the Treatment of Complement-Mediated Diseases
Venkat R Gadhachanda, Jason A Wiles, Steven D Podos, et al.
Page
of 12